Predictive value of fibrinogen-to-albumin ratio in acute coronary syndrome.
Herz
; 45(Suppl 1): 145-151, 2020 Dec.
Article
en En
| MEDLINE
| ID: mdl-31388710
ABSTRACT
BACKGROUND:
We aimed to investigate the predictive value of the fibrinogen-to-albumin ratio (FAR) regarding the development of major cardiovascular events (MACE) in patients treated with percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS).METHODS:
This was a prospective, observational cohort study that included 261 consecutive patients who were treated with PCI. The patients were grouped according to the occurrence of MACE during the follow-up period.RESULTS:
During follow-up, MACE occurred in 68 (26%) patients. The FAR was independently predictive of MACE (HR 1.017, 95% CI 1.010-1.024, pâ¯< 0.001). In addition, left ventricular ejection fraction (LVEF) and a diagnosis of ST-segment elevation myocardial infarction (STEMI) were independent predictors of MACE. The area under the curve (AUC) of the multivariable model, including LVEF and diagnosis of STEMI, was 0.707 (95% CI 0.631-0.782, pâ¯< 0.001). When the FAR was added to the multivariable model, the AUC was 0.770 (95% CI 0.702-0.838, zâ¯= 2.820, difference pâ¯= 0.0048).CONCLUSION:
The FAR could be used for the prediction of MACE in patients with ACS who have undergone PCI.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Síndrome Coronario Agudo
/
Intervención Coronaria Percutánea
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Herz
Año:
2020
Tipo del documento:
Article
País de afiliación:
Turquía